LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | Mitoxantrone | 10 | uM | LJP6 | 72 | hr | 2543 | 295 | 5418 | 0.0546 | -0.8617 |
SK-BR-3 | Mitoxantrone | 10 | uM | LJP5 | 72 | hr | 2543 | 494 | 5752 | 0.0860 | -0.7514 |
SK-BR-3 | AT-7519 | 10 | uM | LJP6 | 72 | hr | 2543 | 697 | 5418 | 0.1286 | -0.6947 |
SK-BR-3 | Omipalisib | 10 | uM | LJP6 | 72 | hr | 2543 | 702 | 5418 | 0.1296 | -0.6926 |
SK-BR-3 | AZD 5438 | 10 | uM | LJP6 | 72 | hr | 2543 | 733 | 5418 | 0.1352 | -0.6804 |
SK-BR-3 | CGP60474 | 10 | uM | LJP6 | 72 | hr | 2543 | 739 | 5418 | 0.1364 | -0.6782 |
BT-20 | A443654 | 10 | uM | LJP6 | 72 | hr | 1334 | 232 | 3925 | 0.0593 | -0.6746 |
SK-BR-3 | LDN-193189 | 10 | uM | LJP5 | 72 | hr | 2543 | 768 | 5752 | 0.1337 | -0.6393 |
BT-20 | CGP60474 | 10 | uM | LJP6 | 72 | hr | 1334 | 278 | 3925 | 0.0711 | -0.6374 |
BT-20 | AT-7519 | 10 | uM | LJP6 | 72 | hr | 1334 | 285 | 3925 | 0.0728 | -0.6302 |
MCF 10A | Canertinib | 10 | uM | LJP6 | 72 | hr | 1694 | 115 | 11217 | 0.0103 | -0.6274 |
SK-BR-3 | Alvocidib | 10 | uM | LJP6 | 72 | hr | 2543 | 878 | 5418 | 0.1624 | -0.6228 |
BT-20 | CGP60474 | 3.33 | uM | LJP6 | 72 | hr | 1334 | 295 | 3925 | 0.0753 | -0.6212 |
SK-BR-3 | Alvocidib | 3.33 | uM | LJP6 | 72 | hr | 2543 | 902 | 5418 | 0.1663 | -0.6137 |
SK-BR-3 | Alvocidib | 0.37 | uM | LJP6 | 72 | hr | 2543 | 905 | 5418 | 0.1666 | -0.6127 |
SK-BR-3 | Geldanamycin | 10 | uM | LJP5 | 72 | hr | 2543 | 837 | 5752 | 0.1456 | -0.6121 |
SK-BR-3 | Alvocidib | 1.11 | uM | LJP6 | 72 | hr | 2543 | 911 | 5418 | 0.1679 | -0.6102 |
SK-BR-3 | AT-7519 | 3.33 | uM | LJP6 | 72 | hr | 2543 | 913 | 5418 | 0.1686 | -0.6092 |
BT-20 | GSK1059615 | 10 | uM | LJP6 | 72 | hr | 1334 | 312 | 3925 | 0.0796 | -0.6087 |
BT-20 | Alvocidib | 10 | uM | LJP6 | 72 | hr | 1334 | 317 | 3925 | 0.0807 | -0.6034 |
SK-BR-3 | BMS345541 | 10 | uM | LJP6 | 72 | hr | 2543 | 933 | 5418 | 0.1724 | -0.6013 |
BT-20 | CGP60474 | 10 | uM | LJP5 | 72 | hr | 1334 | 330 | 4033 | 0.0819 | -0.5837 |
BT-20 | AT-7519 | 3.33 | uM | LJP6 | 72 | hr | 1334 | 350 | 3925 | 0.0894 | -0.5784 |
SK-BR-3 | SNS-032 | 10 | uM | LJP6 | 72 | hr | 2543 | 993 | 5418 | 0.1835 | -0.5780 |
SK-BR-3 | GSK1059615 | 10 | uM | LJP5 | 72 | hr | 2543 | 937 | 5752 | 0.1629 | -0.5732 |